Johnson & Johnson finalises terms of FDA consent decree
Johnson & Johnson, the multinational healthcare giant, has announced it has finalised the terms of a consent decree with the FDA over its stricken McNeil PPC manufacturing plants.
Archives for March 16, 2011
IMC and IC Axon merge to create comprehensive training provider
Informed Medical Communications (IMC) a healthcare communications and training provider, has merged with training program designer and developer, IC Axon.
CROs report on Japan quake impact
Leading players in the Japanese contract research sector have predicted ongoing disruption to trials in the aftermath of the massive earthquake and tsunami that struck the country last week.
Biopharma key to Pall’s Q2 gains
Life sciences drove Pall’s growth in the second quarter of fiscal 2011, with sales to the biopharmaceuticals sector making the biggest gains.
Cytovance secures $22.5m equity investment from Great Point Partners
Cytovance Biologics, the US-based biopharmaceutical contract manufacturer (CMO), has secured a growth equity investment from Connecticut, US-based private investors, Great Point Partners.
GSK introduces SMS service to combat Nigerian counterfeits
GlaxoSmithKline (GSK) has partnered with Nigeria's National Agency for Food and Drug Administration Control (NAFDAC) to provide a patient SMS verification service for its antibiotic, Ampiclox..